Published in Chem Biol on October 24, 2013
Mutant alpha-synuclein causes age-dependent neuropathology in monkey brain. J Neurosci (2015) 0.88
Linking alpha-synuclein properties with oxidation: a hypothesis on a mechanism underling cellular aggregation. J Bioenerg Biomembr (2014) 0.82
Peeling away the layers of ubiquitin signaling complexities with synthetic ubiquitin-protein conjugates. Curr Opin Chem Biol (2015) 0.78
The challenge of producing ubiquitinated proteins for structural studies. Cells (2014) 0.77
Non-degradative Ubiquitination of Protein Kinases. PLoS Comput Biol (2016) 0.75
Chemical Methods for Encoding and Decoding of Posttranslational Modifications. Cell Chem Biol (2016) 0.75
Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational Modifications. Biomolecules (2015) 0.75
Chemical ubiquitination for decrypting a cellular code. Biochem J (2016) 0.75
Multicolor monitoring of the proteasome's catalytic signature. ACS Chem Biol (2014) 0.75
O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein. Bioorg Med Chem (2017) 0.75
The ubiquitin system. Annu Rev Biochem (1998) 43.36
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet (2004) 7.69
Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem (2003) 6.84
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science (2012) 6.66
NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry (1996) 6.47
Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol (2005) 4.88
Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem (2006) 4.06
Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci U S A (2008) 2.68
Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence. Proc Natl Acad Sci U S A (2009) 2.59
The aggregation and fibrillation of alpha-synuclein. Acc Chem Res (2006) 2.17
Induction of alpha-synuclein aggregation by intracellular nitrative insult. J Neurosci (2001) 2.16
Disulfide-directed histone ubiquitylation reveals plasticity in hDot1L activation. Nat Chem Biol (2010) 1.80
Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. Prog Brain Res (2010) 1.57
Chemically ubiquitylated PCNA as a probe for eukaryotic translesion DNA synthesis. Nat Chem Biol (2010) 1.51
Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J Biol Chem (2006) 1.48
Siah-1 facilitates ubiquitination and degradation of synphilin-1. J Biol Chem (2003) 1.33
Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death. Hum Mol Genet (2007) 1.33
Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells. J Biol Chem (2007) 1.32
The size of the proteasomal substrate determines whether its degradation will be mediated by mono- or polyubiquitylation. Mol Cell (2012) 1.30
Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Proc Natl Acad Sci U S A (2004) 1.29
Ultrafast protein splicing is common among cyanobacterial split inteins: implications for protein engineering. J Am Chem Soc (2012) 1.16
α-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc Natl Acad Sci U S A (2011) 1.13
Genetic mouse models of Parkinson's disease The state of the art. Prog Brain Res (2010) 1.12
Ubiquitination of alpha-synuclein. Biochemistry (2005) 1.05
Semisynthetic, site-specific ubiquitin modification of α-synuclein reveals differential effects on aggregation. J Am Chem Soc (2012) 0.95
Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation. J Neurol Sci (2011) 0.85
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci (2005) 3.92
Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis. Nat Struct Mol Biol (2004) 2.25
Trehalose is required for growth of Mycobacterium smegmatis. J Biol Chem (2004) 1.44
Structure-activity analysis of semisynthetic nucleosomes: mechanistic insights into the stimulation of Dot1L by ubiquitylated histone H2B. ACS Chem Biol (2009) 1.33
Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells. J Biol Chem (2007) 1.32
Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Proc Natl Acad Sci U S A (2004) 1.29
Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Hum Mol Genet (2003) 1.22
Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1. Proc Natl Acad Sci U S A (2011) 1.21
Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein. J Biol Chem (2002) 1.20
Probing glycosyltransferase activities with the Staudinger ligation. J Am Chem Soc (2004) 1.15
Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. J Biol Chem (2007) 1.15
Anthrax lethal toxin induced lysosomal membrane permeabilization and cytosolic cathepsin release is Nlrp1b/Nalp1b-dependent. PLoS One (2009) 1.14
α-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc Natl Acad Sci U S A (2011) 1.13
Homogeneous glycopeptides and glycoproteins for biological investigation. Annu Rev Biochem (2001) 1.13
A full-length group 1 bacterial sigma factor adopts a compact structure incompatible with DNA binding. Chem Biol (2008) 1.11
Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation. J Biol Chem (2005) 1.01
An alkyne-aspirin chemical reporter for the detection of aspirin-dependent protein modification in living cells. J Am Chem Soc (2013) 1.00
Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation. Neuroreport (2003) 0.97
The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein--implications for Parkinson's disease. FASEB J (2007) 0.96
Semisynthetic, site-specific ubiquitin modification of α-synuclein reveals differential effects on aggregation. J Am Chem Soc (2012) 0.95
Initial stages of radial glia astrocytic transformation in the early postnatal anterior subventricular zone. J Neurobiol (2002) 0.95
Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol (2001) 0.93
Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation. J Biol Chem (2009) 0.93
Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition. Neurobiol Dis (2005) 0.92
Covalent capture of phospho-dependent protein oligomerization by site-specific incorporation of a diazirine photo-cross-linker. J Am Chem Soc (2007) 0.91
Changes in metabolic chemical reporter structure yield a selective probe of O-GlcNAc modification. J Am Chem Soc (2014) 0.90
Precise control of protein concentration in living cells. Angew Chem Int Ed Engl (2010) 0.86
Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients. Proc Natl Acad Sci U S A (2006) 0.86
α-Synuclein ubiquitination and novel therapeutic targets for Parkinson's disease. CNS Neurol Disord Drug Targets (2014) 0.84
A dual small-molecule rheostat for precise control of protein concentration in Mammalian cells. Chembiochem (2014) 0.84
O-GlcNAc modification prevents peptide-dependent acceleration of α-synuclein aggregation. Chembiochem (2012) 0.83
Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease. Cell Cycle (2006) 0.82
Robust in-gel fluorescence detection of mucin-type O-linked glycosylation. Bioorg Med Chem Lett (2011) 0.82
N-Propargyloxycarbamate monosaccharides as metabolic chemical reporters of carbohydrate salvage pathways and protein glycosylation. Chem Commun (Camb) (2012) 0.81
Using chemistry to investigate the molecular consequences of protein ubiquitylation. Chembiochem (2014) 0.80
AF-6 is a positive modulator of the PINK1/parkin pathway and is deficient in Parkinson's disease. Hum Mol Genet (2013) 0.80
Extent of inhibition of α-synuclein aggregation in vitro by SUMOylation is conjugation site- and SUMO isoform-selective. Biochemistry (2015) 0.79
Chemical reporter for visualizing metabolic cross-talk between carbohydrate metabolism and protein modification. ACS Chem Biol (2014) 0.79
Incorporation of unnatural sugars for the identification of glycoproteins. Methods Mol Biol (2013) 0.76
Periphilin is a novel interactor of synphilin-1, a protein implicated in Parkinson's disease. Neurogenetics (2010) 0.76
Small-molecule reprogramming of cancer metabolism. Chem Biol (2012) 0.75
The sulfur-linked analog of O-GlcNAc (S-GlcNAc) is an enzymatically stable and a reasonable structural-surrogate for O-GlcNAc at the peptide and protein levels. Biochemistry (2017) 0.75
Synthesis of thioether-linked analogues of the 2,3-sialyl-TF and MECA-79 antigens: mucin-type glycopeptides associated with cancer and inflammation. Chembiochem (2003) 0.75
The new chemical reporter 6-alkynyl-6-deoxy-GlcNAc (6AlkGlcNAc) reveals O-GlcNAc modification of the apoptotic caspases that can block the cleavage/activation of caspase-8. J Am Chem Soc (2017) 0.75